Verona pharma to report fourth quarter and full year 2022 financial results and provide corporate update

London and raleigh, n.c., feb. 21, 2023 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma” or the “company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended december 31, 2022 on tuesday, march 7, 2023 and host an investment community conference call at 9:00 a.m. est / 2:00 p.m. gmt to discuss these financial results and provide a corporate update.
VRNA Ratings Summary
VRNA Quant Ranking